Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis

Published:2022-06-16 Issue:4 Volume:26 Page:369-382
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Kastora Stavroula L.^ORCID,Pana Tiberiu A.,Sarwar Yusuf,Myint Phyo K.,Mamas Mamas A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40291-022-00597-z.pdf

Reference49 articles.

1. Cancer Research UK. Breast cancer survival statistics. Published 2021. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/survival?_gl=1*1p4rtww*_ga*OTEwMDU0OTEyLjE2MzIyNTEzMDk.*_ga_58736Z2GNN*MTYzMjc1MjMyNS4yLjEuMTYzMjc1MjQxNi40NQ..&_ga=2.115066242.482372446.1632752326-910054912.1632251309. Accessed 2 Sep 2021.

2. Asselain B, Barlow W, Bartlett J, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39. https://doi.org/10.1016/s1470-2045(17)30777-5.

3. Henriksen P. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart. 2017;104(12):971–7. https://doi.org/10.1136/heartjnl-2017-312103.

4. Hurvitz S, McAndrew N, Bardia A, et al. A careful reassessment of anthracycline use in curable breast cancer. NPJ Breast Cancer. 2021. https://doi.org/10.1038/s41523-021-00342-5.

5. Early Breast Cancer Trialists’ Collaborative Group. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet. 2012;379(9814):432–44. https://doi.org/10.1016/s0140-6736(11)61625-5.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine;Current Issues in Molecular Biology;2023-10-15

2. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis;European Journal of Preventive Cardiology;2023-07-27

3. Cardiac RGS7 and RGS11 drive TGFβ1‐dependent liver damage following chemotherapy exposure;The FASEB Journal;2023-07-13

4. Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology;Current Cardiology Reports;2023-02-15

5. Galectin-3 and Myeloperoxidase May Monitor Cancer-Therapy-Related Cardiotoxicity? A Systematic Review and Meta-Analysis;Biomolecules;2022-11-30